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Background: The interaction between tumor cells and inflammatory cells has not been systematically investigated
in esophageal squamous cell carcinoma (ESCC). The main aims of the study were to investigate the clinical significance of
tumor-infiltrating neutrophils and neturophil-to-CD8+ lymphocyte ratio (NLR), and to analyze the distribution of
tumor-infiltrating neutrophils and CD8+ lymphocytes in ESCC treated by curative resection.
Methods: The expressions of CD66b and CD8 were assessed with double staining immunohistochemistry in the surgical
specimens from 90 patients with ESCC treated by curative surgery.
Results: We showed that increased intratumoral neutrophils were significantly associated with lymph node metastasis
(P = 0.016), and advanced pathological stages (P = 0.013). Decreased peritumoral CD8+ lymphocyte density was more
frequently observed in patients with single positive lymph node (p = 0.045). Peritumoral NLR was significantly associated
with advanced T stages (p < 0.001), lymph node metastasis (p = 0.041) and a trend towards advanced pathological
stages (p = 0.053). Increased intratumoral neutrophils were significantly associated with decreased disease-free survival
(p < 0.001) and overall survival (p < 0.001) in univariate analysis and were identified as an independent prognostic factor
for disease-free survival (p = 0.006) and overall survival (p = 0.037) in multivariate analysis. Neither the density nor the
distribution of tumor-infiltrating neutrophils was significantly correlated with that of CD8+ lymphocytes. The density of
intratumoral CD8+ lymphocytes was significantly lower than (P < 0.001) and moderately correlated with (r = 0.434,
p < 0.001) that in peritumoral area.
Conclusions: Increased intratumoral neutrophils were an independent poor prognostic factor and peritumoral NLR was
significantly associated with disease progression in ESCC treated by curative surgery, suggesting the possible effect of
immune misbalance of tumor microenvironment in facilitating ESCC progression. Immunotherapy targeted to the
above predictors should be considered in the future.
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Esophageal cancer is the eighth most common cancer
type and the sixth leading cause of cancer death world-
wide, which was responsible for 482 300 new cases and
406 800 deaths in 2008 [1]. In China, esophageal cancer
represents a major health problem, which is the fourth* Correspondence: qlcyf1965@163.com
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reproduction in any medium, provided the orleading cause of cancer death. Squamous cell carcinoma
accounts for more than 90% of esophageal cancer cases
in Chinese patients [2]. Despite the advancement in diag-
nosis and treatment modalities, esophageal squamous cell
carcinoma (ESCC) still shows a dismal prognosis with a
5-year survival rate less than 15% [3,4]. The current prog-
nostic model is mainly based on pathological parameters
such as histological subtype, tumor size and pathological
tumor-node-metastasis (pTNM) classification, which aretd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prognostic biomarkers.
Immune reaction was proposed as the seventh hall-
mark of cancer [5]. The importance of interaction be-
tween neoplastic cells and inflammatory cells is becoming
increasingly recognized [6]. Leukocyte infiltration is one
main characteristic of almost all malignant tumors and
the major constituents of these infiltrates include tumor-
associated macrophages, neutrophils, mast cells, NK cells,
lymphocytes, and so on, but the prognostic value of these
infiltrates is still controversial.
Neutrophils, which represent 50%–70% fraction of total
circulating leukocytes, make up a significant portion of the
leukocyte infiltration in a wide variety of human cancers
[7]. Although commonly encountered within tumor micro-
environment, neutrophils have not been traditionally con-
sidered as a disease modifying entity. Many type of cells
within the tumor microenvironment are capable of se-
creting neutrophil chemotactic substances and neutro-
phils recruited to tumor site seem to promote cancer
cell migration and invasion [8]. Increasing evidence indi-
cated that the presence of neutrophils in tumor tissue be
associated with poor prognosis [9-11]. Jensen and col-
leagues [9] examined the infiltration of neutrophils in 121
localized renal cell carcinomas and showed that the pres-
ence of intratumoral neutrophils is an independent poor
prognostic factor. Rao et al. [11] provided evidence that
increased intratumoral neutrophils be important in the ac-
quisition of a malignant phenotype and predict adverse
prognosis in colorectal carcinomas. However, until now,
the prognostic effect of tumor-infiltrating neutrophils in
ESCC remains unknown.
An elevation in blood neutrophil-to-lymphocyte ratio
is considered as a marker of systemic inflammation,
which predisposes the tumor to proliferate and metastasize
through inhibition of apoptosis, promotion of angiogenesis,
and damage of DNA [12-14]. Recent evidence has shown
that a high preoperative blood neutrophil-to-lymphocyte
ratio was associated with poor outcome in various malig-
nancies undergone potentially curative resection, including
esophageal cancer [15,16]. However, the interaction be-
tween immune system and tumor cells mostly take place
around the tumor tissue. The neutrophil-to-lymphocyte ra-
tio in tumor tissue may also serve as an immune marker of
prognostic significance. Cytotoxic CD8+ lymphocytes are
crucial components of tumor-specific cellular adaptive
immunity and constitute the predominant lymphocyte
infiltration in tumor tissue. It is necessary to study the
clinical significance of neturophil-to-CD8+ lymphocyte
ratio (NLR) in tumor tissue. To date, the prognostic ef-
fect of tumor-infiltrating NLR has not been investigated
in ESCC.
The main aims of the study were to investigate the clin-
ical significance of tumor-infiltrating (intratumoral andperitumoral) neutrophils and NLR, and to analyze the
distribution of tumor-infiltrating neutrophils and CD8+
lymphocytes in ESCC treated by curative resection. The
prognostic effect of tumor-infiltrating CD8+ lympho-
cytes was also studied.
Materials and methods
Patients and specimens
Between January 1st and December 31st 2007, 90 pa-
tients, who underwent potential radical surgery for ESCC
in Department of Thoracic Surgery at Qilu Hospital of
Shandong University, were included in the study. Patients
were already excluded because of neoadjuvant treatment,
perioperative mortality, distant metastasis, stage 0 disease,
resection not for curative intent, lost to follow up and lack
of tumor tissue. The protocol of the study was approved
by the Institutional Ethic Committee of Qilu Hospital of
Shandong University. All the patient demographic and
clinical data including age, gender, histological grade,
lymph node status, pTNM stage, and adjuvant treat-
ment were abstracted from the clinical records. Tumor
staging was based on the American Joint Committee on
Cancer (AJCC) 6th edition staging manual [17]. A thorough
histological examination was made using H&E-stained tis-
sue preparation and the histological grade was determined
according to the degree of differentiation of the tumor.
Follow-up visits were performed every 3 months for the
first 2 years after surgery and thereafter every 6 months up
to death or the end of the study (December 2012) for pa-
tients without death. At each visit, a clinical history was
taken and a physical examination was performed. Rout-
ing diagnostic imaging methods included barium meal
fluoroscopy and computer tomography. Disease-free sur-
vival (DFS) was measured from the date of operation to
the date of first evidence of relapse or death, whichever
was observed first. For patients who had not relapsed or
died, DFS was censored at the last date that the absence of
relapse was confirmed. Overall survival (OS) was measured
from the date of surgery to the date of death or last follow-
up for surviving patients [18].
Immunohistochemistry
Formalin-fixed paraffin-embedded surgical specimens were
used for the immunohistochemical analysis. The presence
of available tumor was confirmed by hematoxylin and eosin
staining. The tissue blocks were sectioned at 2 μm and
mounted on glass slides. Primary antibodies were against
CD8 (clone C8/144B, diluted at 1:100, DAKO Corporation
Carpenteria, CA, USA) and CD66b (clone G10F5, diluted
at 1:200, BD Biosciences, San Jose, CA, USA). Double
staining of CD66 and CD8 was carried out with DouSP
KIT (Maixin-bio, Jinan, China) to analyze the densities
and distributions of CD66+ neutrophils and CD8+ lym-
phocytes following the manufacturer's protocol with some
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and rehydrated through a graded ethanol series. Antigen
retrieval was performed with 0.01 M citrate buffer (pH 6.0)
in a pressure cooker for 3 min. Then endogenous perox-
idase activity was blocked with endogenous peroxidase
blocking solution and non-specific protein-binding sites
were blocked through 20 min incubation with non-
immune serum at room temperature.
The anti-CD8 antibody was applied for at 37°C for
1.5 h followed by three 5-min washes with PBS. After in-
cubated with biotinylated-labeled second antibody for
30 min, slides were rinsed three times in PBS for 5 min
and then incubated in streptavidin alkaline phosphatase
complex. After color development with the BCIP/NBT
reagent, the sections were washed with PBS, followed by
the double-stain amplifier provided with the kit. The anti-
CD66b primary antibody was applied at room temperature
for 1.5 h, and washed with PBS. Then, the biotinylated-
labled second antibody was applied for 30 min followed
by streptavidin peroxidase. The immunohistochemical
staining was visualized with AEC reagent. Finally, the
sections were stained with hematoxylin for 1 min and
mounted with an aqueous mounting medium supplied
with the kit.
Evaluation of immunostaining
The analysis was performed with an Olympus IX71S1F-3
Inverted Microscope by two independent observers (Yibin
Jia and Nana Wang) blinded to the patients’ clinicopath-
ological details. The average of the values obtained by
the two observers was recorded. Intratumoral leukocytes
were determined as neutrophils or CD8+ lymphocytes that
infiltrated into cancer nests or stroma, whereas peritu-
moral leukocytes were the cells that distributed along the
tumor-myometrial or tumor-connective tissue junction.
The tumor sections were screened at low power magnifi-
cation (×100), and 6 high power fields (×400) with highest
number of cell infiltration in either intratumoral or
peritumoral areas for neutrophils or CD8+ lympho-
cytes were selected. The median leukocyte count was
used as cutoff to categorize each case into either a high
or low group. Areas of necrosis and artifacts and cells
within the vessels were omitted. The intratumoral or
peritumoral NLR was calculated according to the method
of one previous study [19]. NLR was categorized as
either ≥ or <1.
Statistical analysis
Statistical analyses were performed with the SPSS statistical
software package (SPSS version 13.0; Chicago, IL). Differ-
ences between groups were compared using the chi-square
test for categorical variables and the Student t test for con-
tinuous variables. Associations between continuous vari-
ables were examined by calculating Pearson's correlationcoefficient. For univariate analysis, survival curves were
obtained with the Kaplan-Meier method and compared
by log-rank test. The Cox proportional hazard regression
model was used to identify independent prognostic fac-
tors. All statistical tests were 2-sided, and P values <0.05
indicated of statistical significance.
Results
Patient characteristics
Part of the patient characteristics are listed in Table 1.
Median age was 60.5 years (range, 42 to 78 years), and
80% of patients were male. Tumor locations were upper
thoracic in 10 patients, middle thoracic in 48 patients,
and lower thoracic in 32 patients. The median length of
the tumor was 4 cm (range, 0.5-8.5 cm). The histopatho-
logical differentiations were poor in 26 cases, moderate
in 39 cases, and well in 25 cases. 59 patients (65.6%) had
T3/T4 tumors. 33 patients (36.7%) have positive lymph
nodes. The pathological stages were stage I in 18 patients,
stage II in 41 patients and stage III in 31 patients. 55 pa-
tients (61.1%) received surgery alone, 10 (11.1%) received
postoperative chemotherapy, 16 (17.8%) received postop-
erative radiotherapy and 9 (10%) received postoperative
chemoradiation. 63 patients (70%) had recurrence and 57
patients (63.3%) died during the follow-up. The estimated
1-, 3-, 5-year DFS and OS rates were 76%, 48%, 36% and
89%, 56%, 41%, respectively. Median DFS was 31.7 months
(range, 1.5 to 71.5 months). Median OS was 45.5 months
(range, 2.6 to 71.5 months).
Analysis of immunohistochemical parameters
Representative images of neutrophil and CD8+ lymphocyte
infiltration are shown in Figure 1. The median densities of
intratumoral and peritumoral neutrophils were 18.5 cells/
HPF (range, 0–387 cells/HPF) and 19 cells/HPF (range, 0–
247 cells/HPF), respectively. The median densities of intra-
tumoral and peritumoral CD8+ lymphocytes were 19 cells/
HPF (range, 0–122 cells/HPF) and 32 cells/HPF (range, 0–
200 cells/HPF), respectively. Infiltration of neutrophils or
CD8+ lymphocyte was identified in both stroma and islet
of the tumor, and there were no marked differences in neu-
trophil or CD8+ lymphocyte density between different
intratumoral areas. The density of intratumoral neutrophils
was not significantly different from that of peritumoral
areas (p = 0.348). The density of intratumoral CD8+ lym-
phocytes was significantly lower than that of peritumoral
area (p < 0.001). The distribution of neutrophils was not
associated with that of CD8+ lymphocytes. The density of
intratumoral neutrophils were not significantly associated
with that of intratumoral CD8+ lymphocytes (r = 0.005,
p = 0.966), and the density of neutrophils in peritumoral
areas were not significantly correlated with that of CD8+
lymphocytes in peritumor (r = −0.127, p = 0.232), either.
The density of intratumoral neutrophil was not significantly
Table 1 Correlation of intratumoral CD66+ neutrophils, CD8+ lymphocytes and NLR with clinicopathological parameters
Total Intratumoral neutrophilsa Intratumoral CD8+ lymphocytesa Intratumoral NLR
90 Low High P value Low High P value <l ≥1 P value
Gender
Male 72 34 38 0.292 36 36 1.0 39 33 0.46
Female 18 11 7 9 9 8 10
Age 42-78
<60.5b 45 25 20 0.292 28 17 0.02 21 24 0.291
≥60.5 45 20 25 17 28 26 19
Tumor location
Upper 10 5 5 1.0 6 4 0.438 6 4 0.858
Middle 48 24 24 21 27 25 23
Lower 32 16 16 18 14 16 16
Tumor length 0.5-8.5
<4b 52 21 23 0.673 21 23 0.673 20 24 0.209
≥4 38 24 22 24 22 27 19
Differential Grade
Well 25 14 11 0.764 11 14 0.744 12 13 0.777
Middle 39 19 20 21 18 22 17
Poor 26 12 14 13 13 13 13
T stage
1 and 2 31 18 13 0.267 15 16 0.824 17 14 0.719
3 and 4 59 27 32 30 29 30 29
LN metastasis
Negative 57 34 23 0.016 29 28 0.827 30 27 0.919
Positive 33 11 22 16 17 17 16
Positive LN
0 57 34 23 0.055 29 28 0.968 30 27 0.835
1 12 4 8 6 6 7 5
≥2 21 7 14 10 11 10 11
pTNM stage
I 18 12 6 0.013 8 10 0.87 12 6 0.343
II 41 24 17 21 20 21 20
III 31 9 22 16 15 14 17
Recurrence
Yes 63 24 39 0.001 32 31 0.818 31 32 0.382
No 27 21 6 13 14 16 11
LN lymph node, pTNM pathological tumor node metastasis, NLR, CD66+ neutrophil-to-CD8+ lymphocyte ratio, values in bold signify p < 0.05, aGrouped by
median, bThe median.
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The density of intratumoral CD8+ lymphocytes was mod-
erately correlated with that in peritumoral area (r = 0.434,
p < 0.001). For patients with lymph node metastasis,
CD8+ lymphocyte density in intratumoral area was also
significantly correlated with that in peritumor (r = 0.55,
p = 0.001).Correlation of immunohistochemical parameters with
clinicopathological parameters
As is shown in Tables 1 and 2, increased intratumoral neu-
trophils was significantly associated with lymph node me-
tastasis (P = 0.016), advanced pTNM stages (P = 0.013) and
recurrence (p = 0.001). High intratumoral CD8+ lympho-
cytes were more frequently observed in elder patients (p =
Figure 1 Representative examples of immunostaining of CD66b + neutrophils (in red) or CD8+ lymphocytes (in black) from intratumoral
(A, B, C, D) or peritumoral (E, F, G, H) areas of esophageal squamous cell carcinoma (x400). A, E infiltrated mainly by CD66b + neutrophils (black
arrow); B, F infiltrated mainly by CD8+ lymphocytes (white arrow); C, G infiltrated by both CD66b + neutrophils and CD8+ lymphocytes; D, H infiltrated
by low density of the inflammatory cells.
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clinicopathological parameters. Peritumoral neutrophil den-
sity was not associated with the studied clinicopathologi-
cal parameters. Decreased peritumoral CD8+ lymphocyte
density was more frequently observed in patients with sin-
gle positive lymph node (p = 0.045). Increased peritumoral
NLR was associated with male gender (p = 0.009), ad-
vanced T stages (p < 0.001), positive lymph node metasta-
sis (P = 0.041) and a trend towards advanced pathological
stage (p = 0.053).
Survival analysis
To identify variables of potential prognostic significance
in the patients with ESCC, univariate and multivariate
analyses were employed to investigate the impact of
tumor-infiltrating neutrophils, CD8+ lymphocytes, NLR
and other clinicopathological parameters on the prognosis
of the 90 ESCC patients. In univariate analysis, increased
intratumoral neutrophils were significantly associated with
poor DFS (p < 0.001) and OS (p < 0.001) (Figure 2). No
prognostic significance was found for intratumoral and
peritumoral CD8+ lymphocytes, intratumoral and peritu-
moral NLR and peritumoral neutrophils. The 5-year DFS
and OS rates for patients with increased intratumoral
CD66+ neutrophils were 20% and 26.7%, compared with
51.1% and 55.5% for patients with decreased intratumoral
CD66+ neutrophils, respectively. Clinicopathological fac-
tors significantly associated with short DFS were mod-
erate differentiation, pT4 stage, lymph node metastasis
and advanced pTNM stages. Variables significantly as-
sociated with poor OS were advanced T stages, lymphnode metastasis, advanced pTNM stages and adjuvant
radiation (Table 3). Multivariate analysis revealed that
upper tumor location, advanced pTNM stages and in-
creased intratumoral neutrophils were independently asso-
ciated with decreased DFS and advanced pTNM stages,
postoperative radiation, and increased intratumoral neutro-
phils were independent predictors for poor OS (Table 4).
Discussion
Inflammation seems to play a crucial role in cancer de-
velopment by promoting or restraining progression, angio-
genesis and metastasis, and impacting response to systemic
therapies [20]. Neutrophils and lymphocytes, which consti-
tute the predominant proportion of total circulating leuko-
cytes, play a key role in host systemic immune response,
but their effect on tumor progression should mostly be
realized in the tumor microenvironment. In the present
study, we utilized the methods of double staining immu-
nohistochemistry to investigate the prognostic value of
tumor-infiltrating neutrophils, CD8+ lymphocytes and
NLR and to analyze the distribution of tumor-infiltrating
neutrophils and CD8+ lymphocytes in ESCC treated by
curative resection. Our study firstly established that in-
creased intratumoral neutrophils were significantly corre-
lated with lymph node metastasis and advanced pTNM
stages, and increased peritumoral NLR was significantly
associated with depth of invasion, lymph node metastasis
and a trend towards advanced pathological stages in ESCC
treated by curative resection. Moreover, univariate and
multivariate analyses revealed that increased intratumoral
neutrophils were a prognostic factor for poor DFS and
Table 2 Correlation of peritumoral CD66+ neutrophils, CD8+ lymphocytes and NLR with clinicopathological parameters
Total Peritumoral neutrophilsa Peritumoral CD8+ lymphocytesa Peritumoral NLR
90 Low High P value Low High P value <l ≥1 P value
Gender
Male 72 38 34 0.292 37 35 0.598 40 32 0.009
Female 18 7 11 8 10 16 2
Age 42-78
<60.5b 45 25 20 0.292 25 20 0.292 27 18 0.664
≥60.5 45 20 25 20 25 29 16
Tumor location
Upper 10 6 4 0.612 6 4 0.769 6 4 0.634
Middle 48 25 23 24 24 28 20
Lower 32 14 18 15 17 22 10
Tumor length 0.5-8.5
<4.0b 52 18 26 0.092 20 24 0.399 30 14 0.254
≥4.0 38 27 19 25 21 26 20
Differential grade
Well 25 9 16 0.185 14 11 0.764 12 13 0.221
Middle 39 20 19 19 20 26 13
Poor 26 16 10 12 14 18 8
T stage
1 and 2 31 18 13 0.267 12 19 0.12 27 4 <0.001
3 and 4 59 27 32 33 26 29 30
LN metastasis
Negative 57 27 30 0.512 26 31 0.274 40 17 0.041
Positive 33 18 15 19 14 16 17
Positive LN
0 57 27 30 0.764 26 31 0.045 40 17 0.014
1 12 7 5 10 2 3 9
≥2 21 11 10 9 12 13 8
pTNM stage
I 18 9 9 0.972 8 10 0.536 13 5 0.053
II 41 21 20 19 22 29 12
III 31 15 16 18 13 14 17
Recurrence
Yes 63 31 32 0.818 32 31 0.818 38 25 0.569
No 27 14 13 13 14 18 9
LN lymph node, pTNM pathological tumor node metastasis, NLR CD66+ neutrophil-to-CD8+ lymphocyte ratio, values in bold signify p < 0.05, aGrouped by median,
bThe median.
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tures, including depth of invasion, lymph node metastasis,
and pTNM stages.
Neutrophils are short-lived white blood cells derived
from bone marrow myeloid precursors. Attention has long
been focused on their short-term antimicrobial and tissue-
damaging function. However, growing evidence recently
suggests that neutrophils play an important role in host’sreaction to cancer [21]. The presence of tumor-associated
neutrophils have been demonstrated to be associated with
poor clinical outcomes of several malignancies including
clear cell renal cell carcinoma [9], gastric cancer [22],
colorectal cancer [11], and hepatocellular carcinoma [10].
The present study firstly investigated the clinical signifi-
cance of tumor infiltrating neutrophils in ESCC. Our re-
sults revealed that intratumoral neutrophils be a significant
Figure 2 Kaplan-Meier analysis of intratumoral CD66b +
neutrophils of 90 patients with esophageal squamous cell
carcinoma. Increased intratumoral neutrophils were significantly
associated with decreased disease-free survival (A) and overall
survival (B).
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which was consistent with the results of previous studies in
other tumors.
Currently, the exact role of neutrophils in cancer ini-
tiation, progression and metastasis remains unclear. It
has been hypothesized that tumor-associated neutro-
phils may have different states of differentiation which
can thus take an anti-tumorigenic (“N1-phenotype”) versus
a pro-tumorigenic (“N2”) phenotype [23]. The states of
neutrophils in tumor tissue were recognized by expression
of immuno-activating cytokines and chemokines, and cap-
ability of killing tumor cells. In models of lung cancer, infil-
trating neutrophils are driven by TGF-b to acquire aprotumor phenotype. The phagolysosomes of neutrophils
contain several enzymes capable of reducing molecular
oxygen into superoxide radicals. Reactive oxygen species
from neutrophils were reported to exert both genotoxic
effects and carcinogenesis [24]. Neutrophils could also
release a group of proteinases including neutrophil elastase,
matrix metalloproteinase-8, and matrix metalloproteinase-9
to process and degrade a wide range of cytokines, chemo-
kines, and their cognate receptors, in addition to their
well-described ability to remodel extracellular matrix and
enhance angiogenesis, which could promote the invasion
and metastasis of cancer cells [25-27].
It is well recognized that cytotoxic CD8+ lymphocytes
constitute one of the most important effector mechanisms
of anti-tumor immunity [28]. In both animal models and
humans, CD8+ lymphocytes have been shown to play an
important role in the host's defense against malignancies,
and most cancer vaccine strategies have focused on the in-
duction of effector CD8+ lymphocytes that kill tumor cells
[29]. It has been shown that a high infiltration of CD8+
lymphocytes be associated with good clinical outcome
in several types of human cancer, including cancer of
esophagus [30-33]. However, other studies did not show
the clinical significance of tumor infiltrated CD8+ lym-
phocytes [34]. The inconsistent results in different studies
could be explained by discrepancies in sample size, study
population, treatment modality, and pathological type. In
our study, we did not found any association between
intratumoral or peritumoral CD8+ lymphocyte infiltration
and clinicopathological parameter such as depth of inva-
sion, pathological stages, or clinical outcome. Only when
analyzed by positive lymph node number, low peritumoral
CD8+ lymphocytes were associated with one lymph node
metastasis. Tumor-infiltrating CD8+ lymphocytes could
not predict progression or prognosis in ESCC treated by
curative resection. Our results indicated that the antitu-
mor effect of CD8+ lymphocytes could be partly impaired
in the microenvironment of esophageal squamous cell car-
cinoma, especially in the intratumoral area. The impair-
ment may be mediated by the following mechanisms:
immunosuppressing factors released by tumor cells, defi-
cient tumor antigen presentation by dendritic cells, re-
duced production of costimulating cytokines by helper
CD4+ T-cells, and recruitment of regulatory immune cells
by tumor cells [35].
Recently, great interests have been generated in eluci-
dating the role of cancer inflammation in predicting dis-
ease load and prognosis. Blood neutrophil to lymphocyte
ratio has been found to be associated with disease pro-
gression in a number of malignancies [36]. However, the
systemic immune cells must infiltrate the tumor tissue
to function their antitumor or protumor effect. Cancer
cells recruit inflammatory cells, including neutrophils,
which can suppress the action of cytotoxic lymphocytes.
Table 3 Univariate analysis of clinicopathological and immunohistochemical parameters
Univariate analysis Disease-free survival Overall survival
HR (95% CI) P value HR (95% CI) P value
Gender 1.182 (0.64-2.185) 0.593 1.154 (0.608-2.19) 0.661
Age 1.092 (0.665-1.793) 0.727 1.27 (0.753-2.144) 0.37
Tumor location
Upper Ref. 0.213 Ref. 0.6
Middle 0.517 (0.2554-1.202) 0.083 0.653 (0.286-1.493) 0.312
Lower 0.553 (0.545-1.608) 0.135 0.698 (0.296-1.65) 0.413
Tumor length 1.172 (0.715-1.923) 0.529 1.343 (0.797-2.262) 0.269
Differential Grade
Well Ref. 0.095 Ref. 0.17
Moderate 1.947 (1.045-3.629) 0.036 1.881 (0.971-3.645) 0.061
Poor 1.334 (0.666-2.672) 0.417 1.449 (0.697-3.015) 0.321
T stage
T1 Ref. 0.121 Ref. 0.026
T2 1.359 (0.539-3.454) 0.519 1.425 (0.477-4.253) 0.526
T3 1.954 (0.871-4.385) 0.104 2.706 (1.061-6.9) 0.037
T4 3.328 (1.113-9.951) 0.031 4.618 (1.404-15.196) 0.012
LN metastasis 2.506 (1.51-4.157) <0.001 2.469 (1.455-4.188) 0.001
Positive LN number
0 Ref. 0.001 Ref. 0.002
1 3.479 (1.756-6.89) <0.001 3.01891.491-6.112 0.002
≥2 2.117 (1.176-3.812) 0.012 2.20391.195-4.063 0.011
pTNM stage
I Ref. <0.001 Ref. <0.001
II 2.03 (0.919-4.482) 0.08 2.334 (0.951-5.729) 0.064
III 4.365 (1.962-9.713) <0.001 5.254 (2.139-12.91) <0.001
Treatment regimens
Surgery alone Ref. 0.081 Ref. 0.063
Adjuvant chemotherapy 0.839 (0.354-1.993) 0.692 0.747 (0.291-1.919) 0.545
Adjuvant radiation 1.821 (0.961-3.451) 0.066 1.99 (1.04-3.807) 0.038
Adjuvant chemoradiation 2.152 (0.992-4.67) 0.053 2.054 (0.902-4.676) 0.086
Immunohistochemical markers
Intratumoral neutrophils 2.505 (1.496-4.196) <0.001 2.559 (1.487-4.406) <0.001
Intratumoral CD8+ lymphocytes 0.896 (0.546-1.471) 0.665 0.959 (0.57-1.613) 0.875
Intratumoral NLR 1.279 (0.78-2.097) 0.329 1.316 (0.783-2.214) 0.3
Peritumoral neutrophils 1.035 (0.63-1.7) 0.893 1.119 (0.664-1.886) 0.672
Peritumoral CD8+ lymphocytes 0.952 (0.581-1.561) 0.846 1.032 (0.613-1.735) 0.907
Peritumoral NLR 1.306 (0.788-2.165) 0.3 1.292 (0.761-2.195) 0.343
LN lymph node, pTNM pathological tumor node metastasis, NLR CD66+ neutrophil-to-CD8+ lymphocyte ratio, HR hazard ratio, CI confidence interval, Ref.
reference, Values in bold signify p < 0.05.
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to induce a tumor facilitating cytotoxic lymphocytes.
Currently, evidence is limited about the prognostic effect
of tumor-infiltrating NLR in malignancies. Marius et al.
[19] assessed the prognostic impact of intratumoral NLR inresectable non-small cell lung cancer and found it as an
independent prognostic factor for a high rate of disease
recurrence and poor survival. Another study showed
that elevated intratumoral NLR was significantly associated
with decreased DFS and OS in hepatocellular carcinoma
Table 4 Independent predictors for survival by multivariate analysis
Multivariate analysis Category compared HR (95% CI) P value
Disease-free survival
Tumor location Upper vs. middle and lower 0.474 (0.228-0.987) 0.046
pTNM stage I, II vs. III 1.892 (1.104-3.241) 0.02
Intratumoral neutrophils <18.5 vs. ≥18.5 2.174 (1.249-3.784) 0.006
Overall survival
pTNM stage I, II vs. III 2.122 (1.205-3.736) 0.009
Treatment regimens Surgery alone vs. Adjuvant radiation 1.855 (1.061-3.244) 0.03
Intratumoral neutrophils <18.5 vs. ≥18.5 1.858 (1.038-3.325) 0.037
pTNM pathological tumor node metastasis, HR hazard ratio, CI confidence interval.
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http://www.translational-medicine.com/content/12/1/7following resection [10]. In the present study, we firstly an-
alyzed the clinical significance of both intratumoral and
peritumoral NLRs in ESCC treated by curative surgery. Al-
though no prognostic effect of intratumoral or peritumoral
NLR was shown, we interestingly found that increased
peritumoral NLR was associated with depth of invasion,
lymph node metastasis and a trend towards advanced
pathological stages. In the peritumoral region of ESCC, in-
filtrating neutrophils may suppress the cytotoxic response
of CD8+ lymphocytes and thereby allow tumor cells to
evade immune surveillance. The results are in agreement
with recent findings showing that, in mice, naturally acti-
vated neutrophils in the tumor microenvironment were
mainly of the polarized N2 phenotype promoting tumor
progression, partly associated with suppression of CD8+
lymphocytes [23]. However, this does not preclude the pos-
sibility that peritumoral microenvironment with high neu-
trophil and low CD8+ lymphocyte infiltration is more
suitable for tumor invasion and both immune cells do not
act on each other directly.
Human tumor tissue can be anatomically classified into
areas of intratumor and peritumor, each with distinct com-
positions and functional properties. The density of intratu-
moral neutrophil was not significantly different from or
correlated with that of peritumoral area, whereas the dens-
ity of intratumoral CD8+ lymphocytes was significantly
lower than and moderately correlated with that of peritu-
moral area. Infiltrating of intratumoral CD8+ lymphocyte
may partly determined by recruitment of the lymphocytes
in the peritumoral region. Intratumoral environment usu-
ally exhibited a generalized immunosuppressive status,
resulting in a relatively low density of intratumoral cytoxic
CD8+ lymphocytes. We observed great discrepancies in
the amount of both neutrophil and CD8+ lymphocyte in-
filtration between different patients. The mechanism why
patients may be associated with mild or extensive level of
inflammatory cells remains unclear. In addition, it has
been found that the density of intratumoral neutrophils
was significantly correlated with that of CD8+ lympho-
cytes in resected hepatocellular cell carcinoma [10]. Neu-
trophil depletion could result in more activated CD8+lymphocytes intratumorally [23]. However, in our study,
neither the distribution nor the density of neutrophils was
correlated with that of CD8+ lymphocytes in ESCC, which
suggest that the recruitment of the two types of inflamma-
tory cells may represent different characteristic of ESCC
that do not correlated directly.
Conclusions
In conclusion, we showed that increased intratumoral CD
66+ neutrophils were an independent prognostic factor for
poor DFS and OS in ESCC treated by curative surgery.
Moreover, we demonstrated that increased peritumoral
NLR was a predictor for advanced T stages, lymph node
metastasis and a trend towards advanced disease stages.
This indicated that the progression of ESCC may be gov-
erned at least in part by the state of the local innate im-
mune response. This might also aid the clinician to select a
suitable therapy for the individual patients, e.g. favoring a
more aggressive regimen in tumors with an increased intra-
tumoral neutrophils or misbalance of peritumoral neutro-
phil and CD8+ lymphocytes. Moreover, Immunotherapy
targeted to the above predictors may also help improve the
prognosis of esophageal cancer.
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